Production (Stage)
Pasithea Therapeutics Corp.
KTTA
$0.69
$0.00070.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.56M | -3.18M | -3.00M | -3.87M | -3.86M |
| Total Depreciation and Amortization | 161.70K | 162.30K | 162.30K | 162.30K | 162.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.50K | 117.00K | 218.20K | 196.60K | 319.80K |
| Change in Net Operating Assets | 316.30K | 455.40K | -501.10K | -531.40K | -942.30K |
| Cash from Operations | -3.06M | -2.44M | -3.12M | -4.04M | -4.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.65M | 300.00 | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -179.30K | -23.90K | 4.54M | -- | -- |
| Cash from Financing | 1.47M | -23.60K | 4.54M | -- | -- |
| Foreign Exchange rate Adjustments | -- | 28.10K | -27.10K | -2.90K | -600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.58M | -2.44M | 1.39M | -4.04M | -4.32M |